Professor Andrew Briggs

BSc (Hons) MSc DPhil


15-17 Tavistock Place
United Kingdom

Professor of Health Economics at the London School of Hygiene & Tropical Medicine, and co-Director of the Global Health Economics Centre at the school, along with Anna Vassall and Mark Jit.  I  previously held the William R Lindsay Chair in Health Economics at the University of Glasgow.  Following a sabbatical at Memorial Sloan Kettering Cancer Center, New York in 2016/17, I remain a Visiting Investigator, collaborating with Dr Peter Bach on value frameworks for oncology medications.

I have  co-authored two textbooks, one published by OUP entitled Decision Modelling for Health Economic Evaluation, and the other published by Wiley entitled Statistical Methods for Cost-Effectiveness Analysis.

I am also Series Editor for OUP's Handbooks in Health Economic Evaluation series.

A link to my GooGle Scholar page:


Department of Health Services Research and Policy
Faculty of Public Health and Policy


Centre for Statistical Methodology
Global Health Economics Centre


Our highly successful Foundations and Advanced Decision Modelling for Health Economic Evaluation courses have been developed for online delivery and include, as a new element for 2021, the ability to follow the practical exercises in the statistical package R as well as in Excel.

For full details and to book a place on the upcoming courses in May and June 2022, please visit the course website.


My main methodological focus of research has been health economic evaluation, particularly statistical methods for cost-effectiveness analysis.  This includes statistical methods for estimation of parameters for cost-effectiveness models as well as statistical analysis of cost-effectiveness alongside clinical trials.  I have a more general interest in epidemiological methods, in particular the use of prognostic scoring methods for predicting health outcomes and the relationship with heterogeneity in cost-effectiveness analysis.

Research Area
Decision analysis
Economic evaluation
Randomised controlled trials
Health economics
United Kingdom
United States of America
South Africa
European Union
North America
Sub-Saharan Africa (all income levels)

Selected Publications

Guidance on the use of complex systems models for economic evaluations of public health interventions.
Breeze PR; Squires H; Ennis K; Meier P; Hayes K; Lomax N; Shiell A; Kee F; de Vocht F; O'Flaherty M
Health economics
Mapping the Insomnia Severity Index Instrument to EQ-5D Health State Utilities: A United Kingdom Perspective.
Chalet F-X; Bujaroska T; Germeni E; Ghandri N; Maddalena ET; Modi K; Olopoenia A; Thompson J; Togninalli M; Briggs AH
PharmacoEconomics - open
The Role of Expert Opinion in Projecting Long-Term Survival Outcomes Beyond the Horizon of a Clinical Trial.
Willigers BJA; Ouwens M; Briggs A; Heerspink HJL; Pollock C; Pecoits-Filho R; Tangri N; Kovesdy CP; Wheeler DC; Garcia Sanchez JJ
Advances in therapy
Health Economic Evaluation Using Markov Models in R for Microsoft Excel Users: A Tutorial.
Green N; Lamrock F; Naylor N; Williams J; Briggs A
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: Updated reporting guidance for health economic evaluations
Husereau D; Drummond M; Augustovski F; de Bekker-Grob E; Briggs AH; Carswell C; Caulley L; Chaiyakunapruk N; Greenberg D; Loder E
Health policy open
See more Publications